What is an ECFC?
An Endothelial Colony Forming Cell is a clonally-derived endothelial progenitor with robust proliferative capacity, true single-cell clonogenicity, and the ability to form perfused vessels in vivo.
ECFCs are isolated by plating mononuclear cells and selecting the late-outgrowth, cobblestone colonies that emerge after 1–3 weeks of culture.
ECFC vs. EPC
Historically, the term "endothelial progenitor cell" (EPC)has been used inconsistently across the literature, often referring to a heterogeneous mix of myeloid cells with no true vasculogenic potential. A 2018 expert consensus resolved this fragmented nomenclature: the only EPC that is genuinely endothelial in lineage and clonogenic potential is the ECFC. The terms are now used synonymously, and ECFC is the accepted name.
ECFC vs. HUVEC
HUVECs are mature endothelial cells harvested from adult umbilical vein tissue — a mixed, terminally-differentiated population with limited proliferative lifespan and donor-to-donor variability. Cord blood ECFCs are clonally isolated progenitors from fresh cord blood, retaining a tip-cell phenotype, far higher clonogenic capacity, and vasculogenic competence that mature HUVECs lack.
Vasculogenesis vs. Angiogenesis — and why it matters
The two mechanisms of blood vessel formation are fundamentally different, and only one requires a true endothelial progenitor.
Vasculogenesis
De novo vessel formation from progenitors
Endothelial progenitors differentiate, assemble, and form perfused vessels where none existed before — the embryonic mechanism, also active in adult neovascularization and in tissue engineering.
Angiogenesis
Sprouting from existing endothelium
Mature endothelial cells in pre-existing vessels migrate, proliferate, and remodel to form new branches — the dominant mechanism in adult tissue and what most in vitro tube-formation assays measure.
Why this matters: If your study requires de novo vessel formation — for tissue engineering, vascular grafts, organoid vascularization, or ischemia models — mature HUVECs cannot deliver. ECFCs are the only widely available primary cell that supports both processes.
Reference: Medina RJ, Barber CL, Sabatier F, et al. Endothelial Progenitors: A Consensus Statement on Nomenclature. Stem Cells Translational Medicine, 2017. Read the consensus paper
Ready to order?
Low-passage CB-ECFCs in stock. Worldwide overnight dry-ice shipping.